GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Forward PE Ratio

Xtant Medical Holdings (FRA:XMS) Forward PE Ratio : 0.00 (As of Jun. 02, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Forward PE Ratio?

Xtant Medical Holdings's Forward PE Ratio for today is 0.00.

Xtant Medical Holdings's PE Ratio without NRI for today is 0.00.

Xtant Medical Holdings's PE Ratio for today is 0.00.


Xtant Medical Holdings Forward PE Ratio Historical Data

The historical data trend for Xtant Medical Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Forward PE Ratio Chart

Xtant Medical Holdings Annual Data
Trend
Forward PE Ratio

Xtant Medical Holdings Quarterly Data
Forward PE Ratio

Competitive Comparison of Xtant Medical Holdings's Forward PE Ratio

For the Medical Devices subindustry, Xtant Medical Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Forward PE Ratio falls into.



Xtant Medical Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Xtant Medical Holdings  (FRA:XMS) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Xtant Medical Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (FRA:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines